Title of article
Promising anticancer therapy: combination of immune checkpoint inhibitors and molecular-targeted agents
Author/Authors
sakurai, toshiharu kindai university - faculty of medicine - department of gastroenterology and hepatology, Osaka, Japan , nishida, naoshi kindai university - faculty of medicine - department of gastroenterology and hepatology, Osaka, Japan , kudo, masatoshi kindai university - faculty of medicine - department of gastroenterology and hepatology, Osaka, Japan
From page
777
To page
779
Abstract
Editorial: Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer death worldwide, and prognosis remains unsatisfactory when the disease is diagnosed at an advanced stage. Sorafenib resistance is one of the main obstacles to the treatment of advanced HCC.
Journal title
Hepatobiliary Surgery and Nutrition
Journal title
Hepatobiliary Surgery and Nutrition
Record number
2655356
Link To Document